Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A (Patricia Allen/EU-Startups)

Patricia Allen / EU-Startups:
Paris-based Aqemia, which aims to scale drug discovery by combining quantum physics algorithms and AI, has raised a €30M Series A  —  Pharmatech startup Aqemia has just raised €30 million in a new funding round.  The Parisian startup is generating a pioneering drug discovery pipeline …